For example, the G-factor, based on the expression of p53 and MMP-7, was found to be a promising factor for predicting the outcome of Stage II/III gastric cancer and possibly to help select the treatment for stage II cancer, thus supplementing the conventional TNM system (31). The gene discussed is TP53; the disease is gastric cancer.